Clinical Trial Diversity Action Plan Guidance Must Return To US FDA Website, Court Says

 
• By Sue Sutter
The Thinker
US government agencies did not take a thoughtful approach to complying with a gender ideology executive order, a court said. (Shutterstock)

More from Litigation

More from United States